Insulin or Dapagliflozin Potentially Improves Microcirculatory Dysfunction or INOCA Related to Culprit Vessels in Diabetic Patients With STEMI After DCB Therapy During Long‐Term Follow‐Up.

Saved in:
Bibliographic Details
Title: Insulin or Dapagliflozin Potentially Improves Microcirculatory Dysfunction or INOCA Related to Culprit Vessels in Diabetic Patients With STEMI After DCB Therapy During Long‐Term Follow‐Up.
Authors: You, Wei1 (AUTHOR), Ma, Xianglian2 (AUTHOR), Xu, Yan3 (AUTHOR), Jin, Xiaoping1 (AUTHOR), Mao, Wenxing1 (AUTHOR), Ji, Meili4 (AUTHOR), Huang, Tianyi1 (AUTHOR), Meng, Peina1 (AUTHOR), Xu, Tian1 (AUTHOR), Wang, Yifei1 (AUTHOR), Zhang, Tianlei1 (AUTHOR), Wu, Zhiming1 (AUTHOR), Ye, Fei1 (AUTHOR) doctor_ye@126.com, Wu, Xiangqi1 (AUTHOR) wuxiangqi@njmu.edu.cn
Source: Journal of Diabetes. Feb2026, Vol. 18 Issue 2, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17530393
DOI:10.1111/1753-0407.70197